2 options
HIV/AIDS Drugs, Patents and the TRIPS Agreement : Issues and Options.
- Format:
- Book
- Government document
- Author/Creator:
- Library of Congress. Congressional Research Service.
- Language:
- English
- Subjects (All):
- Drugs.
- Medicine--Research.
- Medicine.
- Pharmaceutical industry.
- Physical Description:
- 1 online resource (27 pages) : digital, PDF file
- monochrome
- Place of Publication:
- [Place of publication not identified] : [publisher not identified], 2001.
- System Details:
- System requirements: PDF reader software.
- text file
- Summary:
- Examines current dispute between the research-based pharmaceutical industry and certain foreign governments, patient advocacy groups and generic manufacturers regarding patented HIV/AIDS drugs. Reviews fundamentals of patent protection for pharmaceuticals domestically and abroad, and discusses medications used in treating HIV/AIDS. Describes international controversies regarding patents on HIV/AIDS drugs and the potential consequences of these disputes for entrepreneurial drug companies. Reviews legislative issues and options.
- Notes:
- CRS Report.
- Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed July 2010). Reuse except for individual research requires license from ProQuest, LLC.
- Other Format:
- Microfiche version: Library of Congress. Congressional Research Service. HIV/AIDS Drugs, Patents and the TRIPS Agreement
- Access Restriction:
- Restricted for use by site license.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.